Your position:m.limatoxi.com >> EN >> EN >> Formulation >> Clovis files for bankruptcy! The market value once exceeded 10 billion, PARP inhibitors once called AstraZeneca >> article
 
Clovis files for bankruptcy! The market value once exceeded 10 billion, PARP inhibitors once called AstraZeneca
Editor:xuezhe    Clicks:0    Date:2022-12-15 17:28:44
Keyword: AstraZeneca
Healthoo Information:
Clovis files for bankruptcy! The market value once exceeded 10 billion, PARP inhibitors once called AstraZeneca Clovis files for bankruptcy! The market value once exceeded 10 billion, PARP inhibitors once called AstraZeneca
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • AstraZeneca Merck Jointly Release the Results of the Phase 3 Clinical ...
  • Phase III Study of AstraZenecas Innovative Therapy was Successful! A L...
  • AstraZeneca is Considering Buying Its Partner Mereo BioPharma
  • AstraZeneca adjusted business strategy in China
  • AstraZeneca started to build manufacturing fa...
  • AstraZeneca to acquire a generics company&nbs...
  • AstraZeneca to build new manufacturing facili...
  • AstraZeneca begins construction work at Zhang...
  • AstraZeneca planned to built a industry ...
  • AstraZeneca Outsources to China
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map